Results(4704)
The Information System for Research in Primary Care (SIDIAP)
Hospital discharge records
Other
Pharmacy dispensing records
Primary care medical records
Spain
First published:
16/07/2026
Data source
Human
Record completeness: 100%
A Prospective, Long-Term Registry of Patients with a Diagnosis of Spinal Muscular Atrophy (SMA) - (RESTORE)
Argentina
Chile
Greece
Ireland
Japan
Korea, Democratic People's Republic of
Poland
Portugal
Romania
Russian Federation
Taiwan
United States
EU PAS number:
EUPAS41853
First published:
16/07/2026
Study
Ongoing
A Non-interventional Real-World Study on Dose Modifications of Enfortumab Vedotin (EV) in Combination with Pembrolizumab (P) in Previously Untreated Patients with Advanced Urothelial Carcinoma in Germany
Germany
EU PAS number:
EUPAS1000000467
First published:
16/07/2026
Study
Discontinued
DARWIN EU® - Real-World Overall Survival in Patients with Acute Gut GvHD Following Failure of Corticosteroids and Ruxolitinib
Belgium
Denmark
Germany
Spain
United States
EU PAS number:
EUPAS1000001062
First published:
16/07/2026
Study
Ongoing
InGef Research Database
Administrative healthcare records (e.g., claims)
Germany
First published:
15/07/2026
Data source
Human
Record completeness: 93%
Prospective Study to Assess Usage, Adherence, Effectiveness of Cabotegravir LA for Pre-Exposure Prophylaxis in the United States in the OPERA Cohort (219844)
United States
EU PAS number:
EUPAS1000000165
First published:
15/07/2026
Study
Ongoing
IQVIA US PharMetrics® Plus
Administrative healthcare records (e.g., claims)
United States
First published:
14/07/2026
Data source
Human
Record completeness: 51%
A Non-interventional Post Authorisation Safety Study (PASS) of Patients with MoCD Type A Treated with NULIBRY (fosdenopterin)
European Union
United Kingdom
EU PAS number:
EUPAS1000000093
First published:
14/07/2026
Study
Ongoing
An Observational Registry of Abatacept in Patients with Juvenile Idiopathic Arthritis
Austria
Belgium
Brazil
Canada
Denmark
France
Germany
Greece
Hungary
Israel
Italy
Latvia
Mexico
Netherlands
Norway
Peru
Portugal
Puerto Rico
Romania
Russian Federation
Saudi Arabia
Slovakia
South Africa
Spain
United Kingdom
United States
EU PAS number:
EUPAS1000001029
First published:
14/07/2026
Study
Ongoing
DARWIN EU® - Cancer incidence during pregnancy
Norway
Spain
United Kingdom
EU PAS number:
EUPAS1000001059
First published:
14/07/2026
Study
Ongoing
Real World Outcomes of Patients Treated with Vericiguat in German Routine Care (ROVER)
Germany
EU PAS number:
EUPAS1000000221
First published:
14/07/2026
Study
Finalised
MEASuRE: Metreleptin Effectiveness and Safety Registry
France
Germany
Italy
United Kingdom
United States
EU PAS number:
EUPAS1000001052
First published:
13/07/2026
Study
Ongoing
Prospective cohort study to assess the performance of tools to describe the Natural History of CytoMegaloVirus infection and transmission in FAMILIes with children attending daycare centers in France (CMV FAMILI study)
France
EU PAS number:
EUPAS1000001054
First published:
13/07/2026
Study
Planned
A Prospective Post-Marketing Observational Safety Study of Cyramza® (Ramucirumab) in Patients with Gastric or Gastroesophageal Junction Adenocarcinoma in China (I4T-MC-B012)
China
EU PAS number:
EUPAS47676
First published:
13/07/2026
Study
Ongoing
TARGET-EU: Nivolumab plus ipilimumab with chemotherapy versus pembrolizumab with chemotherapy in patients with non-oncogenic metastatic non-small-cell lung cancer with <1% PD- L1 tumour expression
Netherlands
EU PAS number:
EUPAS1000000987
First published:
10/07/2026
Study
Planned
A retrospective observational chart review study to evaluate the clinical effectiveness of treatment with zanamivir 10 mg/ml solution for infusion in a cohort of intensive care unit-treated (ICU) patients with complicated influenza infection (208165)
Netherlands
United Kingdom
EU PAS number:
EUPAS37605
First published:
10/07/2026
Study
Ongoing
An Observational Study to Determine the Incidence of Injection Reactions Among Patients With Multiple Sclerosis Treated With Ocrelizumab Subcutaneous
Argentina
Czechia
United Kingdom
United States
EU PAS number:
EUPAS1000001057
First published:
10/07/2026
Study
Planned
A Post-marketing, Observational, Descriptive Study to Assess the Risk Associated With Pregnancy, the Maternal Complications and Adverse Effects on the Developing Fetus, Neonate, and Infant Among Individuals Exposed to Omaveloxolone During Pregnancy and/or Lactation
United States
EU PAS number:
EUPAS1000000327
First published:
10/07/2026
Study
Planned
REpositioning of Medications IN Dementia (REMIND)
France
EU PAS number:
EUPAS1000000484
First published:
10/07/2026
Study
Ongoing
Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, IDIAPJGol
Spain
First published:
09/07/2026
Institution
Educational Institution
Laboratory/Research/Testing facility
Not-for-profit
ENCePP partner
Association between opioid use and the development of diverticulitis (Opioids Diverticulitis)
Canada
United Kingdom
United States
EU PAS number:
EUPAS104164
First published:
09/07/2026
Study
Finalised
PASS TachoSil Evaluation (PasTel): Short- and long-term safety evaluation of TachoSil in paediatric population
Poland
EU PAS number:
EUPAS1000000505
First published:
09/07/2026
Study
Planned
Estudio de utilización de medicamentos para el tratamiento de la insuficiencia cardíaca (IDIAP-IC-2025) / Drug utilization study of treatments for heart failure (IDIAP-IC-2025)
Spain
EU PAS number:
EUPAS1000000866
First published:
09/07/2026
Study
Ongoing
Utilization patterns of oral therapies in prostate cancer in Tuscany: a retrospective observational study based on regional administrative databases
Italy
EU PAS number:
EUPAS1000001049
First published:
09/07/2026
Study
Ongoing
Pharmacovigilance and Pharmacoepidemiology Research Unit, Department Neurofarba, University of Florence
Italy
First published:
08/07/2026
Institution
Educational Institution
ENCePP partner
National Diabetes Research Platform Scotland
Other
United Kingdom
First published:
08/07/2026
Data source
Human
Record completeness: 97%
Background Incidence Rates of Selected Vaccine Adverse Events of Special Interest in Canada
Canada
EU PAS number:
EUPAS1000001053
First published:
08/07/2026
Study
Ongoing
The Use of Oral Fluoroquinolones in Canada: Drug Utilization Study Update
Canada
EU PAS number:
EUPAS107333
First published:
08/07/2026
Study
Finalised
Post-Marketing Study to Assess the Effectiveness and Safety of RECARBRIO in Chinese Adult Patients With Limited or No Alternative Treatment Options for Susceptible Gram-Negative Bacterial Infections (MK-7655A-035)
China
EU PAS number:
EUPAS1000001027
First published:
08/07/2026
Study
Planned
Nederlandse Cystic Fibrosis Stichting (NCFS)
Netherlands
First published:
07/07/2026
Institution
Patient organisation/association
Unit of adverse drug reactions monitoring (UADRM), University Hospital of Pisa
Italy
First published:
07/07/2026
Institution
Educational Institution
Hospital/Clinic/Other health care facility
ENCePP partner
Belgian Cancer Registry (breast and lung cancer)
Cancer registry
Belgium
First published:
07/07/2026
Data source
Human
Record completeness: 69%
DARWIN EU® - Assessing the feasibility of conducting a causal study on the potential association between beta-blockers and breast cancer
Denmark
Norway
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000001013
First published:
07/07/2026
Study
Ongoing
209696 - A targeted safety study, EPI-ZOSTER-032 VS US DB, to evaluate the safety of Shingrix in adults ≥ 65 years of age in the United States.
United States
EU PAS number:
EUPAS37133
First published:
07/07/2026
Study
Finalised
DARWIN EU® - Multiple myeloma: patient characterisation, treatments, and survival in the period 2012–2024
Denmark
Finland
France
Germany
Norway
Spain
Sweden
EU PAS number:
EUPAS1000000757
First published:
07/07/2026
Study
Finalised
LOWER: Lomitapide Observational Worldwide Evaluation Registry (AEGR-733-025)
Canada
France
Greece
Italy
Netherlands
United Kingdom
United States
EU PAS number:
EUPAS5326
First published:
07/07/2026
Study
Ongoing
PATTERN OF USE AND SAFETY PROFILE OF BRANDED VS GENERIC ANTIEPILEPTIC DRUGS
Italy
EU PAS number:
EUPAS24224
First published:
07/07/2026
Study
Finalised
Comparative Effectiveness and Safety of Drugs used in Rare Neuromuscular and Neurodegenerative Diseases (CAESAR)
Italy
EU PAS number:
EUPAS37983
First published:
07/07/2026
Study
Planned
Maternal Outcomes following RSVpreF Vaccination during prEgnancy (MORE)
United States
EU PAS number:
EUPAS1000000923
First published:
07/07/2026
Study
Ongoing
Compare data sources
Compare data sources